PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33051060-0	2020	Combination of metformin and RG7388 enhances inhibition of growth and induction of apoptosis of ovarian cancer cells through the PI3K/AKT/mTOR pathway.	RG7388	29-35	mechanistic target of rapamycin kinase	Homo sapiens	138-142	
33051060-10	2020	Additionally, in vitro and in vivo results showed that MET and/or RG7388 inhibited the phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway and their combination had a stronger effect.	RG7388	66-72	mechanistic target of rapamycin kinase	Homo sapiens	124-153	
33051060-10	2020	Additionally, in vitro and in vivo results showed that MET and/or RG7388 inhibited the phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway and their combination had a stronger effect.	RG7388	66-72	mechanistic target of rapamycin kinase	Homo sapiens	155-159	
33051060-11	2020	Our findings suggest that the combination of MET and RG7388 enhances growth inhibition and apoptosis induction of ovarian cancer cells through the PI3K/AKT/mTOR pathway and accumulation of intracellular ROS.	RG7388	53-59	mechanistic target of rapamycin kinase	Homo sapiens	156-160